Trial Profile
A Phase II Trial of the Treatment of Polycythemia Vera With Gleevec.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Polycythaemia vera
- Focus Therapeutic Use
- 13 May 2010 New trial record